• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物过敏反应与人类免疫缺陷病毒病

Drug hypersensitivity reactions and human immunodeficiency virus disease.

作者信息

Bayard P J, Berger T G, Jacobson M A

机构信息

Department of Family and Community Medicine, San Francisco General Hospital, CA 94110.

出版信息

J Acquir Immune Defic Syndr (1988). 1992 Dec;5(12):1237-57.

PMID:1453334
Abstract

Drug hypersensitivity reactions are often observed by clinicians treating patients infected with the human immunodeficiency virus (HIV). For certain drugs, the incidence of these reactions appears to be higher than previously reported in the general population. The best example is trimethoprim-sulfamethoxazole, associated with rash, fever, hematologic disturbances, transaminase elevation, and, less frequently, more severe reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and anaphylactic-like reactions. Other sulfa congeners, pentamidine, antituberculosis regimens containing isoniazid and rifampin, amoxicillin-clavulanate, clindamycin, and thalidomide also have been associated with an increased incidence of adverse reactions, some of which could involve allergic mechanisms. Effective dosage and management strategies are needed to prevent or ameliorate hypersensitivity reactions when they occur.

摘要

治疗感染人类免疫缺陷病毒(HIV)患者的临床医生经常会观察到药物过敏反应。对于某些药物,这些反应的发生率似乎高于之前在普通人群中的报道。最典型的例子是甲氧苄啶-磺胺甲恶唑,它会引发皮疹、发热、血液系统紊乱、转氨酶升高,较少见的是更严重的反应,包括史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症和类过敏反应。其他磺胺类同系物、喷他脒、含异烟肼和利福平的抗结核方案、阿莫西林-克拉维酸、克林霉素和沙利度胺也与不良反应发生率增加有关,其中一些可能涉及过敏机制。需要有效的剂量和管理策略来预防或减轻过敏反应的发生。

相似文献

1
Drug hypersensitivity reactions and human immunodeficiency virus disease.药物过敏反应与人类免疫缺陷病毒病
J Acquir Immune Defic Syndr (1988). 1992 Dec;5(12):1237-57.
2
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者对甲氧苄啶-磺胺甲恶唑的不良反应。
Ann Intern Med. 1984 Apr;100(4):495-9. doi: 10.7326/0003-4819-100-4-495.
3
Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.抗结核药物致多重药物过敏反应:5 例 HIV 感染患者。
Int J Tuberc Lung Dis. 2012 Sep;16(9):1260-4. doi: 10.5588/ijtld.11.0187. Epub 2012 Jun 28.
4
Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.皮肤药物不良反应与艾滋病:临床医生的全球视角
Dermatol Clin. 2006 Oct;24(4):459-72, vi. doi: 10.1016/j.det.2006.06.008.
5
Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者中对甲氧苄啶-磺胺甲恶唑不良反应的管理。
Arch Intern Med. 1994 Nov 14;154(21):2402-6.
6
Trimethoprim-sulphamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.对有超敏反应病史的感染人类免疫缺陷病毒的血友病患者进行甲氧苄啶-磺胺甲恶唑口服脱敏治疗。
Dis Markers. 1991 Nov-Dec;9(6):355.
7
Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.药物诱导的全身性过敏反应所致肝损伤的特征。
J Am Acad Dermatol. 2013 Sep;69(3):407-15. doi: 10.1016/j.jaad.2013.03.024. Epub 2013 Apr 28.
8
Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.人类免疫缺陷病毒感染患者的药物超敏反应:具有挑战性的诊断与管理
Asia Pac Allergy. 2014 Jan;4(1):54-67. doi: 10.5415/apallergy.2014.4.1.54. Epub 2014 Jan 31.
9
Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.诊断性斑贴试验可诱发 HIV 感染者出现结核相关性皮肤药物不良反应的全身性反应。
Br J Dermatol. 2016 Jul;175(1):150-6. doi: 10.1111/bjd.14492. Epub 2016 May 26.
10
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.感染人类免疫缺陷病毒患者的药物性中毒性表皮坏死松解症(莱尔综合征)
J Am Acad Dermatol. 1992 Apr;26(4):567-74. doi: 10.1016/0190-9622(92)70082-q.

引用本文的文献

1
Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.哌拉西林/他唑巴坦诱发的药物热,见于一名患有潜在人类免疫缺陷病毒(HIV)感染的老年患者。
BMJ Case Rep. 2016 Jul 20;2016:bcr2016215814. doi: 10.1136/bcr-2016-215814.
2
Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management.人类免疫缺陷病毒感染患者的药物超敏反应:具有挑战性的诊断与管理
Asia Pac Allergy. 2014 Jan;4(1):54-67. doi: 10.5415/apallergy.2014.4.1.54. Epub 2014 Jan 31.
3
Antibiotics-related adverse events in the infectious diseases department of a French teaching hospital: a prospective study.
法国教学医院传染病科抗生素相关不良事件:一项前瞻性研究。
Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1611-6. doi: 10.1007/s10096-013-1920-y. Epub 2013 Jul 23.
4
Azathioprine-induced fever in autoimmune hepatitis.巯嘌呤致自身免疫性肝炎发热。
World J Gastroenterol. 2013 Jul 7;19(25):4083-6. doi: 10.3748/wjg.v19.i25.4083.
5
HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.HIV抗逆转录病毒疗法引起的肝脏、胃肠道和胰腺损伤。
Int J Hepatol. 2012;2012:760706. doi: 10.1155/2012/760706. Epub 2012 Mar 11.
6
Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report.HIV患者抗逆转录病毒药物相关的口腔苔藓样反应:一例报告
Int J Dent. 2010;2010:291072. doi: 10.1155/2010/291072. Epub 2010 Jul 5.
7
Hospitalization due to adverse drug reactions and drug interactions before and after HAART.高效抗逆转录病毒治疗(HAART)前后因药物不良反应和药物相互作用导致的住院情况。
Can J Infect Dis. 2000 Jul;11(4):193-201. doi: 10.1155/2000/123046.
8
Drug-induced skin, nail and hair disorders.药物性皮肤、指甲和毛发疾病。
Drug Saf. 2007;30(11):1011-30. doi: 10.2165/00002018-200730110-00003.
9
Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.抗逆转录病毒疗法相关的严重及危及生命的毒性反应。
Curr Infect Dis Rep. 2003 Oct;5(5):429-438. doi: 10.1007/s11908-003-0023-9.
10
Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.药物不良反应的免疫学原理:药物治疗引发的免疫反应的启动与传播。
Drug Saf. 2000 Dec;23(6):483-507. doi: 10.2165/00002018-200023060-00002.